HomeNRIX • NASDAQ
add
Nurix Therapeutics Inc
Previous close
$10.39
Day range
$10.15 - $10.79
Year range
$8.18 - $29.56
Market cap
801.13M USD
Avg Volume
1.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Aug 2025info | Y/Y change |
|---|---|---|
Revenue | 7.89M | -37.29% |
Operating expense | 13.16M | 12.30% |
Net income | -86.42M | -76.53% |
Net profit margin | -1.09K | -181.50% |
Earnings per share | -1.03 | -53.73% |
EBITDA | -89.36M | -71.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Aug 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 428.83M | -4.29% |
Total assets | 522.47M | 1.73% |
Total liabilities | 150.22M | 9.85% |
Total equity | 372.25M | — |
Shares outstanding | 76.88M | — |
Price to book | 2.15 | — |
Return on assets | -41.02% | — |
Return on capital | -49.22% | — |
Cash Flow
Net change in cash
| (USD) | Aug 2025info | Y/Y change |
|---|---|---|
Net income | -86.42M | -76.53% |
Cash from operations | -57.38M | -36.06% |
Cash from investing | 50.48M | 336.54% |
Cash from financing | 1.16M | -97.48% |
Net change in cash | -5.76M | 67.57% |
Free cash flow | -19.10M | -8.56% |
About
Founded
2009
Headquarters
Website
Employees
286
